Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2020 Jun 3;34(10):2839–2840. doi: 10.1053/j.jvca.2020.05.039

Giant Retroperitoneal Hematoma During Extracorporeal Membrane Oxygenation in a Patient With Coronavirus Disease-2019 Pneumonia

Shao-Hui Guo 1, Sheng-Mei Zhu 1, Yong-Xing Yao 1,1
PMCID: PMC7267793  PMID: 32600997

A 71-YEAR-OLD man was admitted to the intensive care unit because of severe bilateral pneumonia resulting from coronavirus disease-2019. His chief complaints were persistent fever, cough, and shortness of breath. Thoracic computed tomography showed bilateral multiple ground-glass opacities. An arterial blood gas analysis demonstrated a low oxygenation index. The patient received high-flow oxygen therapy via a nasal cannula to maintain his oxygen saturation >90%. After receiving supportive care for 2 days, the patient's respiratory function deteriorated further. Endotracheal intubation was performed, but the patient's oxygen saturation remained approximately 70% despite mechanical ventilation with 100% oxygen. Therefore, percutaneous venovenous extracorporeal membrane oxygenation (ECMO) was initiated. Activated partial thromboplastin time was targeted to 60 seconds using a heparin infusion. Progressive hypotension without apparent cause developed 7 days after ECMO was begun. What is the diagnosis?

Diagnosis: Giant Retroperitoneal Hematoma Formation

Acute respiratory distress syndrome and profound hypoxemia are the main causes of death in coronavirus disease-2019 pneumonia.1 Despite the wide use of mechanical ventilation with low-volume, low-pressure, and prone position ventilation strategies, the mortality is still as high as 60% in severe cases.2 In such situations, ECMO might be a life-saving measure, but it also is associated with hemorrhagic complications.3 , 4 In addition, because of a relatively complex management, various complications may occur during ECMO support.5 , 6

Abdominal computed tomography revealed a large cystic retroperitoneal mass, with extravasation of contrast consistent with a retroperitoneal hematoma. The patient remained hypotensive despite volume resuscitation with crystalloid and packed red blood cell transfusion. An intravenous infusion of norepinephrine was required to temporize the hypotension, but the serum lactate concentration continued to increase. The right internal iliac artery was occluded successfully in the angiography suite, and his hemodynamics stabilized. After the procedure, he was returned to the intensive care unit. The patient eventually was weaned from mechanical ventilation and was discharged from hospital 76 days after the procedure.

Figure 1

Fig. 1.

Fig 1

Computed tomography showing a giant cystic density shadow in the right retroperitoneal renal space, with leakage of contrast medium after enhancement.

Conflict of Interest

The authors have no conflicts of interest to disclose.

References

  • 1.Ruan Q., Yang K., Wang W. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China. Intensive Care Med. 2020;46:846–848. doi: 10.1007/s00134-020-05991-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Yang X., Yu Y., Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475–481. doi: 10.1016/S2213-2600(20)30079-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Henry B.M. COVID-19, ECMO, and lymphopenia: A word of caution. Lancet Respir Med. 2020;8:e24. doi: 10.1016/S2213-2600(20)30119-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Augoustides J.G. Extracorporeal membrane oxygenation – crucial considerations during the coronavirus crisis. J Cardiothorac Vasc Anesth. 2020;34:1720–1722. doi: 10.1053/j.jvca.2020.03.060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Keller S.P. Contemporary approaches in the use of extracorporeal membrane oxygenation to support patients waiting for lung transplantation. Ann Cardiothorac Surg. 2020;9:29–41. doi: 10.21037/acs.2019.12.03. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hoyler M.M., Flynn B., Iannacone E.M. Clinical management of venoarterial extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth. 2020;34:2776–2792. doi: 10.1053/j.jvca.2019.12.047. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cardiothoracic and Vascular Anesthesia are provided here courtesy of Elsevier

RESOURCES